FilingReader Intelligence
Lupin receives FDA observations at two facilities
July 17, 2025 at 03:59 PM UTC•By FilingReader AI
Lupin's Pithampur Unit-2 manufacturing facility received four Form-483 observations following a U.S. FDA inspection from July 8-17, 2025.
The company's Pithampur Unit-3 facility received three Form-483 observations after an FDA inspection from July 7-17, 2025.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:LUPIN•Bombay Stock Exchange
News Alerts
Get instant email alerts when Lupin publishes news
Free account required • Unsubscribe anytime